Vetarissp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-01-19
Share capital
20 000,00 PLN
Activity description

Vetaris offers drop supplements for dogs and cats, produced in the EU in 60 ml bottles without grains or sugar. The formulas support joints and mobility, skin and coat, calmness and digestion, and provide omega-3 from krill oil; ingredients include glucosamine, chondroitin, Lactium®, KSM-66® ashwagandha, curcumin and plant extracts.

Registered address
Aleja Wojska Polskiego 114C, 65-765 Zielona Góra, Poland
Website
vetaris.plWebsite active
Email
Email address current
Social media
Electronic delivery address
AE:PL-31016-44093-UHFED-27

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 4.34kMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 1.88kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 2.27kMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 7.98kMedianUSD 541.73kAverageUSD 10.95m

Industry

Bank accounts

Registered as a VAT taxpayer on 2024-02-12. Active

  • mBank
    mBank
    08 1140 1850 0000 7200 7600 1001
  • mBank
    mBank
    24 1140 1850 0000 7200 7600 1004
  • mBank
    mBank
    51 1140 1850 0000 7200 7600 1003

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Zbigniew Dworzecki Bohdanowicz – Management Board Member
Grzegorz Jankowiecki – Management Board Member
Krystian Paweł Malicz – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board is authorised independently to make declarations concerning the company's proprietary and non-proprietary rights and obligations and to sign on behalf of the company. In the case of a multi-member management board, each member of the management board is authorised independently to make declarations concerning the company's proprietary and non-proprietary rights and obligations and to sign on behalf of the company, as a result of which a right is disposed of or obligations are incurred up to an amount not exceeding PLN 40,000.00 (forty thousand złoty); above this amount, joint action by all members of the management board is required.

Ownership

OwnerSharesShare valueStake
Zbigniew Dworzecki Bohdanowicz (43)
34$1,836.8434%
Grzegorz Jankowiecki (33)
32$1,728.8032%
Krystian Paweł Malicz (31)
34$1,836.8434%

Beneficial owners

Person

Competitors

Name
Simedusp. z o.o.
Support-Pharmasp. z o.o.
Endolink PharmaS.A.
Jacek Waksmundzki Trust 2S.K.A.
BIATsp. z o.o.
Move-Xsp. z o.o.
HA Technologiessp. z o.o.
Orthoguardsp. z o.o.
Agri Starsp. z o.o.
Ormigosp. z o.o.

FAQ

Last updated: 2026-10-07